Expert: Mycoplasma pneumoniae, Covid-19 and influenza virus have similar symptoms. It is recommended to confirm the etiology before taking the medicine.

  CCTV News:On November 13th, the National Health and Wellness Commission held a press conference on the prevention and treatment of respiratory diseases in winter. Tong Zhaohui, director of the Beijing Institute of Respiratory Diseases, said that Mycoplasma pneumoniae is one of the common respiratory pathogens. According to our country’s 2016 China community-acquired pneumonia guidelines and relevant data monitoring, Mycoplasma pneumoniae is one of the important causes of community-acquired pneumonia in China, with high incidence in autumn and winter every year, and children and adolescents are susceptible. Mycoplasma pneumoniae is mainly transmitted through respiratory droplets, so without protection, in densely populated places, such as kindergartens and schools, it will lead to concentrated outbreaks. It is also common for family members to be infected with mycoplasma.

Tong Zhaohui said,The detection rate of mycoplasma nucleic acid in adults and children was 5.59% and 40.34% recently. 29.67% of adults and 4.94% of children were positive for influenza antigen. Therefore, acute respiratory infection is a common respiratory disease, and the symptoms caused by mycoplasma pneumoniae, Covid-19 and influenza virus are similar, so the etiological diagnosis can be confirmed by antigen and nucleic acid detection. Therefore, it is recommended that you use drugs after confirming the etiology, rather than relying on guessing drug abuse.